Thomson Medical GroupFRA:3H5 Gross Margin % is 73.89% as of Dec. 2025, which is 7% below its 10-year median of 79.41. The stock has 6 warning signs investors should review. Among 630 Healthcare Providers & Services companies, Thomson Medical Group ranks better than 81.11% on this metric.
FRA:3H5's Gross Margin % is ranked better than 81.11% of 630
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs FRA:3H5: 73.18
Thomson Medical Group had a gross margin of 73.89% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Thomson Medical Group was -0.90% per year.
Thomson Medical Group (FRA:3H5) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Thomson Medical Group had a gross margin of 73.89% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Thomson Medical Group Gross Margin % Related Terms
Thomson Medical Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Thomson Medical Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3H5 vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Thomson Medical Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thomson Medical Group Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Thomson Medical Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Thomson Medical Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Thomson Medical Group (FRA:3H5) has a Gross Margin % of 73.89% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Thomson Medical Group and its competitors. This is near median its historical median of 79.41. Over the past decade, Thomson Medical Group's Gross Margin % has ranged from 73.18 to 83.42. According to the industry distribution chart, Thomson Medical Group ranks #119 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 18.9%.
Is Thomson Medical Group's Gross Margin % too high?
Thomson Medical Group's current Gross Margin % of 73.89% is near median its 10-year median of 79.41. Over the past 10 years, this metric has ranged from a low of 73.18 to a high of 83.42. The Healthcare Providers & Services industry median Gross Margin % is 40.08. Thomson Medical Group's value of 73.89% is 84.4% above this industry median. Based on the distribution chart, Thomson Medical Group ranks #119 out of 630 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Thomson Medical Group's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Thomson Medical Group ranks #119 out of 630 companies for Gross Margin %. This places Thomson Medical Group in the top 19% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.08. Thomson Medical Group's value of 73.89% is 84.4% above this benchmark. Historically, Thomson Medical Group's own Gross Margin % has ranged from 73.18 to 83.42 over the past decade. While the company's 10-year median is 79.41 vs. the industry median of 40.08, Thomson Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thomson Medical Group's current Gross Margin % of 73.89% is 84.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Thomson Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thomson Medical Group's current Gross Margin % is 73.89%, which is near median its own 10-year median of 79.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thomson Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Thomson Medical Group (FRA:3H5) is currently considered Possible Value Trap. The stock's GF Value™ is €0.05, compared to a current price of €0.04 — trading 30% below its estimated fair value. The current Gross Margin % is 73.89%, which is near median its 10-year median of 79.41 and 84.4% above the Healthcare Providers & Services industry median of 40.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Thomson Medical Group (FRA:3H5), the current Gross Margin % is 73.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3H5 has been successfully added to your 